Literature DB >> 9826371

Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.

E U Wieckowski1, J F Kokai-Kun, B A McClane.   

Abstract

After binding, Clostridium perfringens enterotoxin (CPE) initially localizes in a small (approximately 90-kDa) complex in plasma membranes. This event is followed by formation of a second membrane complex, referred to as large (160-kDa) complex. Contrary to a previous hypothesis proposing that CPE inserts into intestinal brush border membranes (BBMs) when this toxin is localized in the small complex, this study shows that BBMs do not offer CPE localized in the small complex protection from pronase. However, our experiments indicate that BBMs do substantially protect CPE from pronase when this toxin is localized in large complex. Since the onset of CPE-induced permeability alterations closely coincides with large-complex formation, these new results suggest that CPE-induced alterations in permeability may result from pore formation due to the partial membrane insertion of CPE when this toxin is present in large complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826371      PMCID: PMC108747     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Deletion analysis of the Clostridium perfringens enterotoxin.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity.

Authors:  B A McClane; A P Wnek
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Production, purification, and assay of Clostridium perfringens enterotoxin.

Authors:  J L McDonel; B A McClane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

Review 4.  Molecular mechanisms of action of bacterial protein toxins.

Authors:  G Menestrina; G Schiavo; C Montecucco
Journal:  Mol Aspects Med       Date:  1994

5.  A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity.

Authors:  P C Hanna; B A McClane
Journal:  Mol Microbiol       Date:  1991-01       Impact factor: 3.501

6.  Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.

Authors:  A P Wnek; B A McClane
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 7.  Clostridial disease of the gut.

Authors:  S P Borriello
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

8.  Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin.

Authors:  E U Wieckowski; A P Wnek; B A McClane
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

10.  Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin.

Authors:  J Katahira; N Inoue; Y Horiguchi; M Matsuda; N Sugimoto
Journal:  J Cell Biol       Date:  1997-03-24       Impact factor: 10.539

View more
  8 in total

1.  Identification and characterization of Clostridium perfringens beta toxin variants with differing trypsin sensitivity and in vitro cytotoxicity activity.

Authors:  James R Theoret; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

2.  Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.

Authors:  J F Kokai-Kun; K Benton; E U Wieckowski; B A McClane
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.

Authors:  James G Smedley; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

4.  Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.

Authors:  Jianwu Chen; James R Theoret; Archana Shrestha; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

Review 5.  On the interaction of Clostridium perfringens enterotoxin with claudins.

Authors:  Anna Veshnyakova; Jonas Protze; Jan Rossa; Ingolf E Blasig; Gerd Krause; Joerg Piontek
Journal:  Toxins (Basel)       Date:  2010-06-08       Impact factor: 4.546

6.  The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion.

Authors:  Alida Coppi; Consuelo Pinzon-Ortiz; Christina Hutter; Photini Sinnis
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

7.  Effects of Claudin-1 on the Action of Clostridium perfringens Enterotoxin in Caco-2 Cells.

Authors:  Iman Mehdizadeh Gohari; Jihong Li; Mauricio Navarro; Francisco Uzal; Bruce McClane
Journal:  Toxins (Basel)       Date:  2019-10-09       Impact factor: 4.546

8.  Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.

Authors:  Archana Shrestha; Bruce A McClane
Journal:  MBio       Date:  2013-01-15       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.